Ebrahim S. Delpassand MD, FACN

Dr. Ebrahim Delpassand is the Chairman and Medical Director of Excel Diagnostics and Nuclear Oncology Center. He holds an academic position as Clinical Professor in Radiation Oncology, at the University of Texas, Medical Branch. He completed his residency training in Nuclear Medicine, and Anatomical and Clinical Pathology at Baylor College of Medicine in Houston in 1991. He is Board certified in Nuclear Medicine and Fellow of theAmericanCollegeof Nuclear Medicine.

Dr. Delpassand is the former deputy chairman, associate professor, and chief of clinical nuclear medicine at M.D. Anderson Cancer Center in Houston, Texas. His prestigious credentials and extensive experience include the disciplines of therapeutic nuclear medicine, Peptide Receptor Radionuclide Therapy (PRRT), nuclear cardiology, monoclonal antibody imaging, and positron emission tomography (PET). Dr. Delpassand is the principle Investigator of multiple Investigational New Drug (IND) applications in the areas of diagnostic and Therapeutic Nuclear Medicine authorized by U.S. Food and Drug Administration (FDA).